Corcept Therapeutics (CORT) Current Assets (2010 - 2026)

Corcept Therapeutics (CORT) has 17 years of Current Assets data on file, last reported at $426.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 2.84% year-over-year to $426.0 million; the trailing twelve-month figure through Mar 2026 stood at $426.0 million (down 2.84% YoY), and the FY2025 full-year result was $485.5 million, up 2.94% from the prior year.
• Current Assets fell to $426.0 million in Q1 2026, from $485.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $560.8 million in Q2 2024 to a low of $388.2 million in Q1 2022.
• A 5-year average of $467.8 million and a median of $458.6 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 87.36% in 2022 and retreated 20.99% in 2025, its largest moves.
• Tracing CORT's Current Assets over 5 years: stood at $499.3 million in 2022, then dropped by 8.14% to $458.6 million in 2023, then rose by 2.83% to $471.6 million in 2024, then grew by 2.94% to $485.5 million in 2025, then retreated by 12.24% to $426.0 million in 2026.
• Business Quant data shows CORT's Current Assets at $426.0 million in Q1 2026, $485.5 million in Q4 2025, and $541.1 million in Q3 2025.